Tobias Neff, Executive Medical Director at Merck, shared an article by Fatemeh Alikarami, et al. on LinkedIn:
“This took 10 years to complete, very happy to see it is finally out!
Mechanistic insight why stem-cell like leukemia has such poor outcomes.
Congratulations to Fatemeh Alikarami, Kathrin Bernt and team!”
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Authors: Fatemeh Alikarami, et al.
